Treatment of Displaced Medial Epicondyle Fractures In Children

Status Not yet recruiting

Clinical Trial Summary

Compare the outcome of the operative and non-operative treatment; for fractures of the medial epicondyle of humerus in children as regards union, alignment and complications.

Clinical Trial Description

On the distal humerus, posteromedially, is where the medial epicondyle apophysis is situated. It serves as the starting point for the flexor-pronator muscle and the ulnar collateral ligament. 12-20% of pediatric elbow fractures have been reported to be caused by fractures of the medial humeral epicondyle. Thirty to fifty percent of these fractures result in elbow dislocation, and eighteen to twenty percent of the fracture fragments become lodged in the elbow joint. The medial epicondyle fractures typically happen between the ages of 9 and 14 due to the insufficient ossification of the bone, which makes it more prone to failure early than the stronger soft-tissue attachments. Optimal treatment for pediatric medial epicondyle fractures continues to be a topic of debate. In the face of technical advancements, evolving surgical indications, and societal pressures, there is little concrete data demonstrating the superiority of either operative or non-operative treatment. When a child's medial humeral epicondyle fracture is minimally displaced (less than 2 mm), non-operative therapy is recommended. The PedsQL Pediatric discomfort Questionnaire revealed that children who received non-operative treatment experienced reduced discomfort (3 vs. 15, p = 0.01) and had superior cosmetic results. There is a great deal of disagreement about how to treat displaced fractures (3-15 mm), with some surgeons supporting internal fixation as the non-union rate drops significantly. For upper-extremity athletes who need elbow stability to play their sport, surgery is also advised. Furthermore, it has been proposed that there are no statistically significant variations in outcomes between surgical and non-operative groups. Fractures of the medial humeral epicondyle in children heal well with 3-4 weeks' immobilization. There is no common consensus in treatment of closed medial epicondyle fractures with >2 mm displacement (without incarceration of the fragment inside the joint or ulnar nerve dysfunction) that Open reduction and screw fixation improve outcome. The purpose of our study is to compare the treatment outcomes and complications between operatively and non-operatively treated displaced medial epicondyle fractures. We aim to improve our understanding of the outcomes of these fractures to make treatment recommendations. We hypothesise that there is no difference in treatment outcomes between non-operative and operative treatment. ;

Study Design

Related Conditions & MeSH terms

Fractures, Bone

Clinical Trial Details

NCT number	NCT06454929
Study type	Interventional
Source	Assiut University
Contact	ahmed ezzat M eltaweel, Physician
Phone	01068950894
Email	ahmed.15235479@med.aun.edu.eg
Status	Not yet recruiting
Phase	N/A
Start date	July 1, 2024
Completion date	July 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05555459` - Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation	N/A
Completed	`NCT03147222` - Function Focused Care: Fracture Care at Home	N/A
Completed	`NCT03506958` - Patient Satisfaction in Treatment of Non-complex Fractures and Dislocations in Hospitals vs General Practitioners
Completed	`NCT04426981` - Behavioral Activation in Orthopaedic Trauma Patients: A Pilot Study	N/A
Recruiting	`NCT04389749` - Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures	N/A
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT05594199` - Feasibility of a Virtual Smoking Cessation Program	N/A
Completed	`NCT04514601` - A Quality Improvement Project to Assess and Refine the Handover Process at Morning Trauma Meetings
Completed	`NCT02272972` - Performance Improvement Program on Imaging II
Completed	`NCT05138640` - Bone Strength and Physical Activity in Patients With a Recent Clinical Fracture
Completed	`NCT04215315` - Fracture In Preterm Infants Study (FIPIN Study)
Completed	`NCT03219125` - Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women
Terminated	`NCT05655130` - Distal Radius Steroid	Phase 1
Completed	`NCT04151732` - Factors Associated With Future Fractures in Middle-aged Men and Women
Completed	`NCT02714257` - Working to Increase Stability Through Exercise	N/A
Completed	`NCT02428244` - Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients	N/A
Recruiting	`NCT04501510` - Ultrasonography in Fracture Management
Completed	`NCT03852095` - Single Time Management Diseases in Pediatric Traumatology
Completed	`NCT04440631` - Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection
Completed	`NCT03370900` - Learning Retention in Radiograph Interpretation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.